Tamsulosin HCL & Dutasteride Tablets - FLOCONT PLUS Tablets

FLOCONT PLUS Tablets – Dual Action for Effective BPH Symptom Control.

FLOCONT PLUS Tablets – Tamsulosin HCL & Dutasteride Tablets, a combination therapy, targets benign prostatic hyperplasia (BPH) through dual mechanisms:
Tamsulosin, an alpha-1 adrenergic receptor blocker, relaxes smooth muscle in the prostate and bladder neck to improve urine flow.
Dutasteride, a 5-alpha reductase inhibitor, blocks the conversion of testosterone to dihydrotestosterone (DHT), leading to prostate shrinkage and symptom improvement over time.

Key Benefits of Tamsulosin HCL & Dutasteride Tablets – FLOCONT PLUS Tablets
✅ Alpha-Blocker + 5-ARI Synergy – Tamsulosin provides rapid relief from lower urinary tract symptoms (LUTS), while Dutasteride reduces prostate volume and prevents disease progression.
✅Improves Urinary Flow & Reduces Retention Risk – Combination enhances peak urinary flow rate (Qmax) and lowers the risk of acute urinary retention and need for surgery.
✅Superior Long-Term Management of BPH – Clinically proven to offer better symptom score reduction and quality-of-life improvement than monotherapy.

Recommended by specialists:
👨‍⚕️Urologists: Primary specialists for diagnosing and treating benign prostatic hyperplasia (BPH), for which this combination is commonly prescribed.
👨‍⚕️General Physicians: May initiate or continue treatment in stable BPH cases, especially in older male patients with mild-to-moderate symptoms.
👨‍⚕️Geriatricians: Manage BPH in elderly males as part of comprehensive senior care, often monitoring for side effects and drug interactions.

Indications:
✅Benign Prostatic Hyperplasia (BPH)
✅Lower Urinary Tract Symptoms (LUTS) associated with BPH
✅Prevention of Acute Urinary Retention
✅Long-term Prostate Volume Management